Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0483-2019

Drug recall · February 20, 2019

COSOPT Ophthalmic Solution recall

Why: Failed Stability Specifications: out of specification results for opalescence at 7 month stability study.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10

Lots / codes

Lots: 426007 and 426008, exp 4/2020

Quantity
30,794 bottles
Company
Akorn Inc, Lake Forest, IL
Distribution
Nationwide USA and Puerto Rico
Initiated
December 20, 2018 · Voluntary: Firm initiated
Classified
February 8, 2019
Reported
February 20, 2019
Ended
November 6, 2020
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Timolol

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.